Stock screener

CELZ

Conviction 0FinancialsScan · Mon, Jul 20, 2026
CELZ$0.8599-2.17%
ResistanceSupportVol 14
63 bars
Vol MA14 14.3M
Apr 20May 6May 26Jun 11Jul 1Jul 20
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.creativemedicaltechnology.com
Price0.8599
Change-2.17%
Gap+3.08%
Rel volume0.01×
Avg volume10.13M
Avg $ vol14.48M
SMA 201.20
SMA 501.82
SMA 2002.27
Price vs 50-52.78%
Price vs 200-62.20%
MA stackbearish
50/200 cross
Supertrenddown · 1.56
RSI (14)31
MACD hist-0.00
MACD cross
Stoch %K / %D1 / 2
ADX (14)28
+DI / −DI42 / 24
RSI divergence
MACD divergence
ATR %+28.86%
ADR %24.78%
52w high5.59
52w low0.8102
From 52w high-84.62%
Above 52w low+6.13%
New 52w highNo
SqueezeOff
Bollinger width140.22%
%B0.30
Donchian pos1.78%
Donchian high4.72
Donchian low0.7901
AVWAP (52w high)2.43
vs AVWAP high-64.57%
AVWAP (52w low)2.43
vs AVWAP low-64.55%
OBV trendUp
Chaikin MF (20)-0.91
Today vs 20d0.01×
Avg vol (14d)14.3M
Avg vol (20d)10.13M
Avg $ vol (20d)14.48M
Market cap3.18M
RS 3m (vs SPY)-68.21%
RS 6m (vs SPY)-60.15%
RS line new highNo
Trend template0/8
Technical rank7.5
1 week+0.66%
1 month-61.61%
3 months-65.19%
6 months-54.74%
1 year-67.18%
YTD-56.35%
P/E-0.53
P/B0.52
P/S529.79
P/FCF
EPS-2.52
Div yield
ROE-98.12%
ROA-93.08%
Debt/Eq0.84
Current19.69
EV/EBITDA-0.63
Gross margin63.43%
Net margin
Rev growth-45.45%
EPS growth-9.13%
Price target20.00
Target upside2225.85%
Analyst ratingBuy
Institutional2.75%
Ent. value3.82M
Revenue0
Net income-1.41M
Gross profit0
Free cash flow
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out3.7M
Employees4
ListedThu, Apr 30, 2009
Free float3.66M
Float %99.1%
Short interest602.28K
Days to cover0.0d
Short volume41.0%
Squeeze score34 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.38 vs −$0.39
Last surprise+2.6% beat
Setup gradeD
Conviction0 / 100
Pattern quality
Tech rank7.5 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance3.61
Support0.7961
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CELZ

All disclosures →
No recent disclosed trades by Congress in CELZ. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CELZ

No recent insider (Form 4) filings in CELZ. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in CELZ · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.